Your browser doesn't support javascript.
loading
CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.
Laurent, Lucie; Sefrioui, David; Bignon, Anne-Laure; Parzy, Aurélie; Sidali, Sabrina; Hassine, Mélanie; Gangloff, Alice; Galais, Marie-Pierre; Bouhier-Leporrier, Karine; Michel, Pierre; Di Fiore, Frédéric.
Afiliación
  • Laurent L; Rouen University Hospital, Department of Hepato-Gastroenterology, Digestive Oncology Unit, F 76000, Rouen, France.
  • Sefrioui D; Normandie Univ, UNIROUEN, Inserm U1245, IRON Group, Rouen University Hospital, Department of Hepato-Gastroenterology, Digestive Oncology Unit, F 76000, Rouen, France.
  • Bignon AL; Caen University Hospital, Department of Hepato-Gastroenterology and Nutrition, F 14000, Caen, France.
  • Parzy A; Centre Régional François Baclesse, Digestive Oncology Unit, F 14000, Caen, France.
  • Sidali S; Rouen University Hospital, Department of Hepato-Gastroenterology, Digestive Oncology Unit, F 76000, Rouen, France.
  • Hassine M; Rouen University Hospital, Department of Hepato-Gastroenterology, Digestive Oncology Unit, F 76000, Rouen, France.
  • Gangloff A; Rouen University Hospital, Department of Hepato-Gastroenterology, Digestive Oncology Unit, F 76000, Rouen, France.
  • Galais MP; Centre Régional François Baclesse, Digestive Oncology Unit, F 14000, Caen, France.
  • Bouhier-Leporrier K; Caen University Hospital, Department of Hepato-Gastroenterology and Nutrition, F 14000, Caen, France.
  • Michel P; Normandie Univ, UNIROUEN, Inserm U1245, IRON Group, Rouen University Hospital, Department of Hepato-Gastroenterology, Digestive Oncology Unit, F 76000, Rouen, France.
  • Di Fiore F; Normandie Univ, UNIROUEN, Inserm U1245, IRON Group, Rouen University Hospital, Digestive Oncology Unit and Department of Medical Oncology, Henri Becquerel Centre, Rouen, F 76000, Rouen, France. Electronic address: frederic.difiore@chu-rouen.fr.
HPB (Oxford) ; 21(5): 582-588, 2019 05.
Article en En | MEDLINE | ID: mdl-30466797
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Antígeno CA-19-9 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: HPB (Oxford) Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Antígeno CA-19-9 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: HPB (Oxford) Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Francia